News und Analysen

• 3 Blue-Chip Stocks Built for a Rotating Market

Gilead Sciences (NASDAQ:GILD) Chief Commercial Officer and Head of Corporate Affairs Johanna Mercier said the company is leaning on its HIV business

DRI Healthcare Trust (TSE:DHT.UN) reported higher first-quarter income and expanded margins as management said the royalty investment company continued to benefit from its post-internalization cost

• Viking Sails to All-Time Highs—Fundamentals Signal More to Come

Viking (NYSE:VIK) reported a stronger first quarter for fiscal 2026 and announced a leadership transition, with founder Torstein

MiNK Therapeutics (NASDAQ:INKT) said it is advancing its off-the-shelf invariant natural killer T cell therapy platform into a randomized clinical program for severe acute lung injury and acute

KinderCare Learning Companies (NYSE:KLC) reported modest first-quarter revenue growth while management said lower enrollment in its early childhood education centers continued to pressure

Karyopharm Therapeutics (NASDAQ:KPTI) said it entered 2026 with several near-term clinical and regulatory catalysts, led by new Phase 3 data in myelofibrosis and an expected midyear readout in

AxoGen (NASDAQ:AXGN) President and CEO Michael Dale said the company’s growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are

• High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026

CorMedix (NASDAQ:CRMD) reported sharply higher first-quarter 2026 revenue and profit, driven by continued adoption of DefenCath and the

Cellebrite DI (NASDAQ:CLBT) reported first-quarter 2026 results that management said met or exceeded the high end of its guidance for annual recurring revenue and adjusted EBITDA, while executives

• Breakout Momentum Plays You Need to Know About

Omeros (NASDAQ:OMER) reported first-quarter 2026 net income of $56.1 million, or $0.78 per share, as the company began commercial sales of YARTEMLEA

• The 3 Penny Stocks You Swore You’d Never Buy (But You’ll Check Anyway)

Microvision (NASDAQ:MVIS) said its first-quarter results showed early commercial traction from its expanded lidar portfolio

Lightwave Logic (NASDAQ:LWLG) reported a wider first-quarter loss while outlining progress on customer engagement, foundry integration and commercialization efforts for its electro-optic polymer

• 3 Stocks With Sky-High Short Interest Levels

Allogene Therapeutics (NASDAQ:ALLO) said its first quarter of 2026 was marked by early clinical progress for its lead allogeneic CAR-T programs and a

• Novavax’s dispute resolution and upcoming earnings call

Valneva (NASDAQ:VALN) reported lower first-quarter revenue and a wider loss for 2026, while management said the company is focused on